NYSE:HQL Abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free HQL Stock Alerts $13.23 -0.21 (-1.56%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$13.19▼$13.4750-Day Range$12.79▼$14.2752-Week Range$11.34▼$14.37Volume94,198 shsAverage Volume104,035 shsMarket Capitalization$361.84 millionP/E RatioN/ADividend Yield11.26%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Abrdn Life Sciences Investors alerts: Email Address Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. About Abrdn Life Sciences Investors Stock (NYSE:HQL)Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.Read More HQL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQL Stock News HeadlinesMay 24, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires $17,590.50 in StockMay 18, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires $493,173.45 in StockMay 15, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 57,862 SharesMay 11, 2024 | insidertrades.comSaba Capital Management, L.P. Buys 10,986 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockMay 8, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Purchases 10,713 SharesMay 3, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases $353,648.04 in StockMay 2, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 16,573 SharesApril 30, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 120,304 SharesMay 26 at 7:28 AM | americanbankingnews.comSaba Capital Management, L.P. Purchases 1,303 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockMay 19, 2024 | americanbankingnews.comSaba Capital Management, L.P. Buys 34,755 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockMay 12, 2024 | uk.investing.comSaba Capital Management buys abrdn Life Sciences shares worth $390kApril 30, 2024 | markets.businessinsider.comXlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation ReportMarch 21, 2024 | finance.yahoo.comabrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team UpdateMarch 8, 2024 | msn.comSYRA: Takeaways from Life Science Investor Forum PresentationMarch 1, 2024 | bizjournals.comA 2024 life sciences outlook in Boston – and beyondFebruary 9, 2024 | markets.businessinsider.comabrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in...January 24, 2024 | benzinga.comPeering Into Anavex Life Sciences's Recent Short InterestNovember 23, 2023 | money.usnews.comabrdn Life Sciences InvestorsNovember 2, 2023 | investing.comAbrdn Life Sciences Investors (HQL)September 26, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 10,096 Shares of Tekla Life Sciences ...September 21, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...August 15, 2023 | seekingalpha.comTekla Life Sciences declares $0.32 dividendJune 20, 2023 | finance.yahoo.comabrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUMMay 17, 2023 | msn.comTekla Life Sciences Investors (HQL) Declares $0.32 DividendMay 15, 2023 | msn.comTekla Life Sciences dividend declines by 3% to $0.32See More Headlines Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/28 Dividend2/21/2024Dividend Payable3/28/2024Ex-Dividend for 6/28 Dividend5/22/2024Today5/28/2024Dividend Payable6/28/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Investment offices, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:HQL CUSIPN/A CIK884121 Webwww.teklacap.com Phone(617) 772-8500Fax617-772-8577EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares27,350,000Free Float24,599,000Market Cap$361.84 million OptionableNot Optionable Beta0.73 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Daniel R. Omstead M.S (Age 71)Ph.D., Principal Executive Officer, President and Trustee Mr. Peter BrannerChief Investment OfficerKey CompetitorsTortoise Energy InfrastructureNYSE:TYGDWS Municipal Income TrustNYSE:KTFBlackRock MuniYield New York Quality FundNYSE:MYNHorizon Technology FinanceNASDAQ:HRZNBarings Corporate InvestorsNYSE:MCIView All CompetitorsInsiders & InstitutionsCetera Investment AdvisersBought 10,979 shares on 5/24/2024Ownership: 0.535%Cetera Advisors LLCBought 141,526 shares on 5/24/2024Ownership: 0.517%Saba Capital Management, L.P.Bought 1,303 shares on 5/23/2024Total: $17,590.50 ($13.50/share)B. Riley Wealth Advisors Inc.Bought 11,500 shares on 5/16/2024Ownership: 0.042%Saba Capital Management, L.P.Bought 34,755 shares on 5/15/2024Total: $493,173.45 ($14.19/share)View All Insider TransactionsView All Institutional Transactions HQL Stock Analysis - Frequently Asked Questions How have HQL shares performed in 2024? Abrdn Life Sciences Investors' stock was trading at $13.46 on January 1st, 2024. Since then, HQL shares have decreased by 1.7% and is now trading at $13.23. View the best growth stocks for 2024 here. Are investors shorting Abrdn Life Sciences Investors? Abrdn Life Sciences Investors saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 73,600 shares, an increase of 26.0% from the April 30th total of 58,400 shares. Based on an average daily trading volume, of 83,200 shares, the short-interest ratio is presently 0.9 days. View Abrdn Life Sciences Investors' Short Interest. How often does Abrdn Life Sciences Investors pay dividends? What is the dividend yield for Abrdn Life Sciences Investors? Abrdn Life Sciences Investors announced a quarterly dividend on Thursday, May 9th. Investors of record on Thursday, May 23rd will be given a dividend of $0.48 per share on Friday, June 28th. This represents a $1.92 annualized dividend and a dividend yield of 14.51%. The ex-dividend date is Wednesday, May 22nd. This is an increase from the stock's previous quarterly dividend of $0.39. Read our dividend analysis for HQL. Is Abrdn Life Sciences Investors a good dividend stock? Abrdn Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.49 per share and currently has a dividend yield of 11.09%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for HQL. What ETFs hold Abrdn Life Sciences Investors' stock? ETFs with the largest weight of Abrdn Life Sciences Investors (NYSE:HQL) stock in their portfolio include Saba Closed-End Funds ETF (CEFS).First Trust Income Opportunities ETF (FCEF). What other stocks do shareholders of Abrdn Life Sciences Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abrdn Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY). Who are Abrdn Life Sciences Investors' major shareholders? Abrdn Life Sciences Investors' stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.58%), Karpus Management Inc. (1.26%), Raymond James Financial Services Advisors Inc. (0.60%), Advisors Asset Management Inc. (0.55%), Cetera Investment Advisers (0.53%) and Cetera Advisors LLC (0.52%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead, Kathleen Goetz, Saba Capital Management, LP and Todd Reit. View institutional ownership trends. How do I buy shares of Abrdn Life Sciences Investors? Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:HQL) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBitcoin’s Biggest Year YetParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.